Skip to main content

Figure 3.

Figure 3

Microvessels (arrows) in the B16F10 tumors stained with antimouse CD34 monoclonal antibody. (a) Neovasclarization of untreated tumor (PBS control). (b) Anti‐angiogenic effect observed in the tumor treated by DC therapy plus intratumoral IL‐12 gene delivery.